Trials / Recruiting
RecruitingNCT05814952
Safety and Efficacy Study of LX103 Treatment of X-Linked Retinoschisis (XLRS)
An Open Label Dose Escalation Clinical Trial to Evaluate the Safety and the Efficacy of LX103 in Patients With X-Linked Retinoschisis (XLRS)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- Male
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to evaluate the safety and efficacy of LX103 treatment of X-linked retinoschisis. This study will enroll subjects aged ≥ 6 years old to receive a single unilateral intravitreal (IVT) injection of LX103 to evaluate its safety and efficacy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | LX103 Injection | Qualified subjects will receive a single unilateral intravitreal injection of LX103 at Day 0 in the trial. |
Timeline
- Start date
- 2022-12-13
- Primary completion
- 2024-08-01
- Completion
- 2028-08-01
- First posted
- 2023-04-18
- Last updated
- 2023-04-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05814952. Inclusion in this directory is not an endorsement.